Comparing two MRI contrast agents for liver imaging
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether a newer contrast agent, gadopiclenol, works as well as the standard one for liver scans. It might be an option if you need an MRI to check for liver disease, tumors, or treatment response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a liver condition or need an MRI to look at liver spots or tumor follow-up.
- You do not have severe kidney problems (GFR less than 30).
- You are not pregnant and have no allergy to gadolinium contrast agents.
- You can have an MRI (no pacemaker, no severe claustrophobia, etc.).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two contrasting dyes (gadopiclenol and gadobutrol) used during pituitary MRI scans to see which one provides clearer images. It is for adults with known or suspected pituitary lesions that disrupt the blood-brain barrier.
This trial studies an MRI technique using a contrast dye (gadopetate/gadolinium) to better look at liver lesions that may be colon cancer spread. It may help doctors more accurately assess which liver tumors are present and guide next steps.
This trial compares two different dyes (gadopiclenol and gadobutrol) used during MRI scans for people with unexpected kidney or adrenal findings. The goal is to see which dye works better for getting clear images of these areas.
This trial tests new MRI (scanner) software and hardware and checks how safely people can complete the scan. You may qualify if you’re an adult who can do MRI safely and (if contrast is used) have adequate kidney function and no relevant allergy.
This study tests different MRI imaging techniques to improve how scans look and measure targets. You may be able to join with or without a contrast dye, and you’ll need to travel to the NIH for follow-up visits.
This study compares two advanced imaging techniques — a combined PET/MR scan and an enhanced MRI — to see which one better finds and shows liver tumors or cancer that has spread to the liver. If you have signs of a liver problem, this trial may help doctors get a clearer picture of your condition.
Hear when a new Liver Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.